We are live on
!
Find out more
CL
Chubb Ltd Portfolio holdings
AUM
$29.9M
1-Year Est. Return
48.89%
This Fund
S&P 500
This Quarter
Est. Return
+2.11%
1 Year Est. Return
-48.89%
3 Year Est. Return
-64.23%
5 Year Est. Return
-53.98%
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$3.78M
(+1.6%)
Cap. Flow
-$229K
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
74.77%
Holding
21
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NewtekOne
NEWT
|
+$4.87K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BP
BP
|
+$234K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.93% |
| 2 | Financials | 23.18% |
| 3 | Energy | 21.23% |
| 4 | Consumer Staples | 7.93% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Morgan Stanley
MS
$332B
| $21.9M | 9.28% |
490,472
| – | – |
|
2
Sanofi
SNY
$105B
| $21.6M | 9.16% |
450,000
| – | – |
|
3
Merck
MRK
$307B
| $19.2M | 8.17% |
314,400
| – | – |
|
4
Archer Daniels Midland
ADM
$41.3B
| $18.6M | 7.91% |
450,000
| – | – |
|
5
JPMorgan Chase
JPM
$901B
| $18.3M | 7.77% |
200,000
| – | – |
|
6
GSK
GSK
$100B
| $17.2M | 7.33% |
320,000
| – | – |
|
7
AstraZeneca
AZN
$255B
| $17M | 7.24% |
250,000
| – | – |
|
8
TotalEnergies
TTE
$180B
| $14.9M | 6.32% |
300,000
| – | – |
|
|
9
BP
BP
$108B
| $13.9M | 5.89% |
451,187
-7,519
| -2% | -$234K |
|
10
Pfizer
PFE
$141B
| $13.4M | 5.71% |
421,600
| – | – |
|
11
Western Union
WU
$2.71B
| $13.3M | 5.67% |
700,000
| – | – |
|
|
SPLS
12
DELISTED
Staples Inc
SPLS
| $12.1M | 5.13% |
1,200,000
| – | – |
|
13
Ericsson
ERIC
$31.6B
| $10.8M | 4.57% |
1,500,000
| – | – |
|
|
RDS.A
14
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $10.6M | 4.52% |
200,000
| – | – |
|
15
Williams Companies
WMB
$90.7B
| $10.6M | 4.5% |
350,000
| – | – |
|
|
NEWS
16
DELISTED
NewStar Financial, Inc.
NEWS
| $835K | 0.35% |
79,551
| – | – |
|
|
QHC
17
DELISTED
Quorum Health Corporation
QHC
| $766K | 0.33% |
184,709
| – | – |
|
|
18
NewtekOne
NEWT
$432M
| $257K | 0.11% |
15,772
+291
| +2% | +$4.87K |
|
|
CYHHZ
19
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
| $40K | 0.02% |
2,000,000
| – | – |
|
20
eGain
EGAN
$182M
| $36K | 0.02% |
21,355
| – | – |
|
|
SSI
21
DELISTED
Stage Stores Inc
SSI
| $34K | 0.01% |
16,491
| – | – |
|
Similar funds
ECM
LN
HSCM
VH
EGA
EOCM
AC
BGP
Chubb Ltd's Q2 2017 Portfolio in Review
As of Q2 2017, Chubb Ltd held 21 positions worth $235M, up 1.6% from $232M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 0%. Chubb Ltd opened no new positions and made no exits, leaving the 21-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Energy.
- Chubb Ltd added most to NewtekOne in Q2 2017, an estimated $4.87K increase.
- Chubb Ltd's biggest Q2 2017 reduction was BP, cutting an estimated $234K.
- Chubb Ltd's ten largest holdings make up 75% of its $235M portfolio in Q2 2017.
- Chubb Ltd opened 0 new positions and closed 0 in Q2 2017.
- Chubb Ltd's portfolio value rose 1.6% quarter-over-quarter to $235M.
Based on Chubb Ltd's 13F filing for Q2 2017, filed 28 Jul 2017.